Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company manufactures pharmaceutical products such as drugs, medicines, syrup and capsules.
G Amphray Pharmaceuticals Private Limited, is an unlisted private company incorporated on 27 February, 1982. It is classified as a private limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 1.95 cr and the total paid-up capital is INR 11.00 lac.
Read more
Buy Dashboard using Credits
** All rupee values in INR crores. Based on March 2024 numbers.
8.57%
-32.57%
-40.62%
15.6%
15.61%
-7.42
-8.0
-6.88
-12.78
27.2
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(3)
| State | Type | Address |
|---|---|---|
| Maharashtra | Registered Office | SAMBAVA CHAMBERS 4TH FLOORSIR P M ROAD MUMBAI Maharashtra - 400001 |
| Maharashtra | Factory, Sales Office | 4th Floor, Samabava Chambers, Sambava CHambers, Sir P M Road, Fort, Mumbai, Maharashtra, 400001 |
| Maharashtra | Factory, Sales Office | Next to Petrol Pump, Plot No 107, MIDC Chickloli, K B Road, Chickloli, Thane, Maharashtra, 421505 |
Locations on Map
Filter (4)
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Grace Ramu Deora
Shareholder
|
00312080 | 19 years |
| Director | Rajesh Ramu Deora
Shareholder
|
00312316 | 20 years |
| Director | Rajiv Ramu Deora
Shareholder
|
00312430 | 34 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| TRIOCHEM PRODUCTS LIMITED |
Active
|
24.5 L | 2 | Maharashtra |
| TRIOCHEM LABORATORIES PVT LTD |
Active
|
11.0 L | 3 | Maharashtra |
| AMBERNATH PLASTO PACKAGING PVT LTD |
Active
|
11.0 L | 3 | Maharashtra |
| DEORA INVESTMENTS PRIVATE LIMITED |
Active
|
11.0 L | 2 | Maharashtra |
| AVAS PROPERTIES AND INVESTMENTS PRIVATE LIMITED |
Strike Off
|
13.9 L | 1 | Maharashtra |
| GENIUNE PROPERTIES AND INVESTMENTS PRIVATE LIMITED |
Strike Off
|
13.7 L | 3 | Maharashtra |
| G AMPHRAY LABORATORIES LLP |
Active
|
1.0 Cr | 1 | Maharashtra |
Severe Risk
Moderate Risk
Low Risk
Read more
The incorporation date of G AMPHRAY PHARMACEUTICALS PRIVATE LIMITED is 27 February, 1982
The authorized share capital of G AMPHRAY PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 1.9 Cr.
The paid-up capital of G AMPHRAY PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 11.0 L.
The registered address of G AMPHRAY PHARMACEUTICALS PRIVATE LIMITED is SAMBAVA CHAMBERS 4TH FLOORSIR P M ROAD MUMBAI Maharashtra - 400001
The CIN number of G AMPHRAY PHARMACEUTICALS PRIVATE LIMITED is U24200MH1982PTC026504.
Expand
Delete
Collapse
See
details
